(5-Chloro-2-(2-(methylamino)thiazol-4-yl)pyridin-4-yl)(4-(4-chlorobenzyl)piperazin-1-yl)methanone, 98.0%, 100mg

2,5-Diaminobenzonitrile, 97.0%, 10g

5-tert-Butyl-4H-1,2,4-triazol-3-amine, = 95% (NMR), 100mg

H-Arg(NO2)-OMe.HCl, 95%, 25g

METHYL 3-FLUORO-4-(2-METHOXY-2-OXOETHOXY)BENZOATE, 95.0%, 500mg

4,4-DIMETHYL-2-(2-(TRIFLUOROMETHYL) PHENYL)-4,5-DIHYDROOXAZOLE, 95.0%, 250mg

Matraces de fondo redondo de tres bocas con cuellos laterales paralelos, 2000 ml, 24/29, 19/26, 1 unidad

2,6-Dichloropyridin-3-ol, 95.0%, 25g

5-Hydroxy-2-methylpyridine, 95.0%, 25g

N-Methyl-1-(pyridin-3-yl)methanamine dihydrochloride, 95.0%, 1g

6-(3-(Cyclopropylmethoxy)-4-methoxyphenyl)-3-(2,5-dimethoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine, 95%, 25mg

3-Bromofuran-2,5-dione, 95.0%, 25g

3-(4-Benzyloxy-3-methoxyphenyl)-4-benzyl-1,2,4-triazoline-5-thione, 95%, 10g